Long COVID top news

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Primary immunodeficiency disease patients have high risk of invasive fungal disease

Publish date:: August 12, 2020

Key clinical point: PID patients are at high risk of developing fungal infections with high mortality.

Major finding: The mortality rate among patients was 10/28 (35.7%).

Study details: A total of 28 PID patients diagnosed with fungal infections were assessed.

Disclosures: There was no outside funding and the authors reported having no conflicts.

Citation:

Elaziz DA et al. Clinical Immunology. 2020; doi.org/10.1016/j.clim.2020.108553.

This Week's Must Reads

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

COVID-19–induced drop in first measles vaccinations sparks resurgence concerns,

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Three genes could predict congenital Zika infection susceptibility,

‘Excellent short-term outcomes’ seen in HCV+ liver transplants to HCV– recipients,

Must Reads in Invasive fungal infections

Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy,

Infection with Fusarium is a risk in hematology patients,

Primary immunodeficiency disease patients have high risk of invasive fungal disease,

MicroRNAs can distinguish invasive aspergillosis in lung transplant recipients,

Saliva-controlled sputum culture aids diagnosis of deep pulmonary infections,